Insider Transactions in Q1 2025 at 89bio, Inc. (ETNB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2025
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,050
-0.33%
|
$10,500
$10.57 P/Share
|
|
Feb 17
2025
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-0.29%
|
$7,800
$10.57 P/Share
|
|
Feb 17
2025
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,249
-0.38%
|
$32,490
$10.57 P/Share
|
|
Feb 17
2025
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,050
-0.3%
|
$10,500
$10.57 P/Share
|
|
Feb 09
2025
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-1.18%
|
$41,987
$11.41 P/Share
|
|
Feb 09
2025
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
3,793
-1.09%
|
$41,723
$11.41 P/Share
|
|
Feb 09
2025
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,828
-1.4%
|
$42,108
$11.41 P/Share
|
|
Feb 09
2025
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,946
-1.02%
|
$98,406
$11.41 P/Share
|
|
Feb 01
2025
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Indirect |
8,750
+37.23%
|
$78,750
$9.6 P/Share
|
|
Feb 01
2025
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
3,338
-0.95%
|
$30,042
$9.6 P/Share
|
|
Feb 01
2025
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+18.53%
|
-
|
|
Feb 01
2025
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,338
-1.2%
|
$30,042
$9.6 P/Share
|
|
Feb 01
2025
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+22.37%
|
-
|
|
Feb 01
2025
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,338
-1.02%
|
$30,042
$9.6 P/Share
|
|
Feb 01
2025
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.65%
|
-
|
|
Feb 01
2025
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,598
-1.09%
|
$86,382
$9.6 P/Share
|
|
Feb 01
2025
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
412,000
+21.07%
|
-
|
|
Feb 01
2025
|
Francis Willard Sarena Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,750
+40.57%
|
-
|
|
Jan 30
2025
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+22.61%
|
$45,714,280
$8.75 P/Share
|
|
Jan 22
2025
|
Charles Mc Wherter |
BUY
Open market or private purchase
|
Direct |
10,000
+28.57%
|
$60,000
$6.71 P/Share
|
|
Jan 21
2025
|
Charles Mc Wherter |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$30,000
$6.55 P/Share
|
|
Jan 15
2025
|
Quoc Le Nguyen |
SELL
Open market or private sale
|
Direct |
10,963
-3.88%
|
$65,778
$6.49 P/Share
|